4 ms·
The profit motive is everywhere in the medical sector, and that is a bad thing. Even if you believe in free markets, it's not easy to get the best care. To sta
by markvdb 6y ago
The profit motive is everywhere in the medical sector, and that is a bad thing. Even if you believe in free markets, it's not easy to get the best care.
To stay cose to the eye as a subject, look at vitreomacular adhesion. Roughly two possible treatments:
- costly and complicated eye surgery
- substantially simpler ocriplasmin [0] injections
In many cases where ocriplasmin looks like it could be the perfect solution, it isn't even considered. Could that have something to do with the surgeon's incentives alignment?
[0] https://en.wikipedia.org/wiki/Ocriplasmin https://en.wikipedia.org/wiki/Ocriplasmin
- ghufran_syed 6y agoAn analogous problem in drugs seems to have been effectively addressed by the Orphan Drug act (https://en.m.wikipedia.org/wiki/Orphan_Drug_Act_of_1983 https://en.m.wikipedia.org/wiki/Orphan_Drug_Act_of_1983) Sounds like maybe there needs to be something similar for medical devices?